141 related articles for article (PubMed ID: 27997427)
1. Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT.
Dubreuil J; Dony A; Salles G; Traverse-Glehen A; Giammarile F; Skanjeti A
Clin Nucl Med; 2017 Feb; 42(2):106-107. PubMed ID: 27997427
[TBL] [Abstract][Full Text] [Related]
2. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
[TBL] [Abstract][Full Text] [Related]
3. Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT.
Sanan P; Lu Y
Clin Nucl Med; 2017 Sep; 42(9):702-703. PubMed ID: 28632694
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET/CT Staging of Oncologic Patients.
Bacanovic S; Stiller R; Pircher M; Burger IA; Huellner MW
Clin Nucl Med; 2016 Aug; 41(8):e394-6. PubMed ID: 27124682
[TBL] [Abstract][Full Text] [Related]
5. [Update on the use of FDG-PET/CT in malignant lymphoma].
Terauchi T
Rinsho Ketsueki; 2016; 57(10):2008-2012. PubMed ID: 27795508
[TBL] [Abstract][Full Text] [Related]
6. Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma.
Györke T; Kollár A; Bottlik G; Szepesi Á; Bodó I; Masszi T; Bérczi V; Garai I
Int J Hematol; 2011 Apr; 93(4):545-550. PubMed ID: 21360009
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
8. Role of FDG PET-CT in the treatment management of Hodgkin lymphoma.
Berriolo-Riedinger A; Becker S; Casasnovas O; Vander Borght T; Édeline V
Cancer Radiother; 2018 Sep; 22(5):393-400. PubMed ID: 30033076
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
10. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT Findings of Nodular Sclerosis-Subtype Classic Hodgkin Lymphoma Presented as Mediastinal Nodal Lesions at Onset But as Predominant Osseous Disease at Relapse.
Zheng K; Zhuang H
Clin Nucl Med; 2017 Jun; 42(6):496-498. PubMed ID: 28418952
[TBL] [Abstract][Full Text] [Related]
12.
Tamayo P; Martín A; Díaz L; Cabrero M; García R; García-Talavera P; Caballero D
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):312-321. PubMed ID: 28483374
[TBL] [Abstract][Full Text] [Related]
13. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
[TBL] [Abstract][Full Text] [Related]
15. Typical and Atypical 18FDG PET/CT Findings in Two Cases of Cat Scratch Disease.
Zhou W; Gong L; Zuo C; Zhang J
Clin Nucl Med; 2019 Jun; 44(6):e388-e391. PubMed ID: 30985438
[TBL] [Abstract][Full Text] [Related]
16. FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma.
Kim J; Chen W; Resnik C; Dilsizian V; Chen Q; Kimball AS
Clin Nucl Med; 2015 Apr; 40(4):325-7. PubMed ID: 25290293
[TBL] [Abstract][Full Text] [Related]
17. Serendipitous Detection of Hodgkin Lymphoma by 18F-NaF PET/CT.
Shao F; Wu J; Huang Z; Zhou F; Chen Y
Clin Nucl Med; 2016 Oct; 41(10):815-8. PubMed ID: 27556800
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT in re-staging of patients with lymphoma.
Freudenberg LS; Antoch G; Schütt P; Beyer T; Jentzen W; Müller SP; Görges R; Nowrousian MR; Bockisch A; Debatin JF
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):325-9. PubMed ID: 14647988
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Knogler T; Sillaber C; Jaeger U; Simonitsch-Klupp I; Ubl P; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Cancer Res; 2015 Jun; 21(11):2506-13. PubMed ID: 25733598
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.
Dubreuil J; Moreau A; Sarkozy C; Traverse-Glehen A; Skanjeti A; Salles G; Giammarile F
Clin Nucl Med; 2016 May; 41(5):397-8. PubMed ID: 26825213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
